Freedman Financial Associates’s Tvardi Therapeutics, Inc. Common Stock TVRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-93
Closed -$42K 482
2022
Q1
$42K Hold
93
0.03% 221
2021
Q4
$41K Sell
93
-4
-4% -$1.76K 0.03% 231
2021
Q3
$54K Hold
97
0.04% 186
2021
Q2
$50K Sell
97
-53
-35% -$27.3K 0.04% 195
2021
Q1
$117K Hold
150
0.1% 94
2020
Q4
$82K Buy
+150
New +$82K 0.07% 115